Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.
Novartis
Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory
Mayzent: New Drug for Treatment of Secondary Progressive Multiple Sclerosis
Siponimod released by Novartis is an improved version of Gilenya.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Arcalyst: World’s First Drug to Treat Recurrent Pericarditis
Rilonacept by Kiniksa Pharmaceuticals will reduce recurrent pericarditis to almost nothing.